Evidence map›Paper›PMID 37117627›Full record

ArticleNature aging2021

Rare genetic coding variants associated with human longevity and protection against age-related diseases.

Jhih-Rong Lin, Patrick Sin-Chan, Valerio Napolioni, Guillermo G Torres, Joydeep Mitra, Quanwei Zhang, M Reza Jabalameli, Zhen Wang, Nha Nguyen, Tina Gao and 18 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Nature aging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. TACR3 variant confers resilience to aging and Alzheimer's disease.medRxiv : the preprint server for health sciences · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Genetic variants associated with age-related episodic memory decline implicate distinct memory pathologies.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Biological resilience in health and disease.Disease models & mechanisms · 2024
    Review
  19. Review
  20. Refeeding-associated AMPKNature aging · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors at 9 institutions in 4 countries.

Jhih-Rong Lin *Department of Genetics, Albert Einstein College of Medicine, New York, NY, USA.
Patrick Sin-Chan *Regeneron Pharmaceuticals Inc., New York, NY, USA.
Valerio NapolioniSchool of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy.ORCID http://orcid.org/0000-0002-4378-6838
Guillermo G TorresInstitute of Clinical Molecular Biology, Kiel University, Kiel, Germany.
Joydeep MitraDepartment of Genetics, Albert Einstein College of Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0001-5806-7329
Quanwei ZhangDepartment of Genetics, Albert Einstein College of Medicine, New York, NY, USA.
M Reza JabalameliDepartment of Genetics, Albert Einstein College of Medicine, New York, NY, USA.
Zhen WangDepartment of Genetics, Albert Einstein College of Medicine, New York, NY, USA.
Nha NguyenDepartment of Genetics, Albert Einstein College of Medicine, New York, NY, USA.
Tina GaoDepartment of Medicine, Albert Einstein College of Medicine, New York, NY, USA.
Regeneron Genetics Center
Matthias LaudesDivision of Endocrinology, Diabetes and Clinical Nutrition, Department of Internal Medicine I, Kiel University, Kiel, Germany.
Siegfried GörgInstitute of Transfusion Medicine, University Hospital Schleswig-Holstein, Lübeck, Germany.
Andre FrankeInstitute of Clinical Molecular Biology, Kiel University, Kiel, Germany.
Almut NebelInstitute of Clinical Molecular Biology, Kiel University, Kiel, Germany.
Michael D GreiciusDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.
Gil AtzmonDepartment of Medicine, Albert Einstein College of Medicine, New York, NY, USA.
Kenny YeDepartment of Epidemiology & Population Health, Albert Einstein College of Medicine, New York, NY, USA.
Vera GorbunovaDepartment of Biology, University of Rochester, Rochester, NY, USA.ORCID http://orcid.org/0000-0001-8979-0333
Warren C LadigesDepartment of Comparative Medicine, School of Medicine, University of Washington, Seattle, WA, USA.
Alan R ShuldinerRegeneron Pharmaceuticals Inc., New York, NY, USA.
Laura J NiedernhoferInstitute on the Biology of Aging and Metabolism and Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN, USA.ORCID http://orcid.org/0000-0002-1074-1385
Paul D RobbinsInstitute on the Biology of Aging and Metabolism and Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN, USA.ORCID http://orcid.org/0000-0003-1068-7099
Sofiya MilmanDepartment of Genetics, Albert Einstein College of Medicine, New York, NY, USA.
Yousin SuhDepartment of Genetics, Albert Einstein College of Medicine, New York, NY, USA.
Jan VijgDepartment of Genetics, Albert Einstein College of Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0002-8457-9595
Nir BarzilaiDepartment of Genetics, Albert Einstein College of Medicine, New York, NY, USA.
Zhengdong D ZhangDepartment of Genetics, Albert Einstein College of Medicine, New York, NY, USA. zhengdong.zhang@einsteinmed.org.ORCID http://orcid.org/0000-0001-9508-1429
Albert Einstein College of Medicine · USChristian-Albrechts-Universität zu Kiel · DERegeneron (United States) · USUniversity of Minnesota · USStanford University · USUniversità di Camerino · ITUniversity Hospital Schleswig-Holstein · DEUniversity of Rochester · USUniversity of Washington · US

Funding

THE IMPACT OF CELLULAR DEFENSE ON THE ROLE OF Ku80 IN GENOME MAINTENANCE AND LONGP01AG017242 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI VIJG, JAN · 1999 to 2023
$46.1M
Validation and characterization of the identified variants associated with human longevity in mouse modelsU19AG056278 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI NIR J BARZILAI, Paul D. Robbins · 2017 to 2026
$24.5M
Resilience to Alzheimer's disease in humans with exceptional longevityR01AG057909 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI BARZILAI, NIR J, ZHANG, ZHENGDONG · 2017 to 2021
$6.2M
Somatotropic Signaling and Resilience to Aging and Alzheimer's DiseaseR01AG061155 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI MILMAN, SOFIYA · 2019 to 2023
$4.3M
The Stanford Extreme Phenotypes in Alzheimer's Disease (StEP AD) CohortR01AG060747 · NIA · STANFORD UNIVERSITY · PI GREICIUS, MICHAEL D · 2018 to 2022
$3.4M
Interpreting human enhancer variants with a network-regularized composite modelR01HG008153 · NHGRI · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI ZHANG, ZHENGDONG · 2016 to 2018
$3.1M
NHGRI NIH HHS R01 HG008153NIA NIH HHS P01 AG017242NIA NIH HHS R01 AG057909NIA NIH HHS R01 AG060747NIA NIH HHS R01 AG061155NIA NIH HHS U19 AG056278
6 · The paper itself

Abstract

Extreme longevity in humans has a strong genetic component, but whether this involves genetic variation in the same longevity pathways as found in model organisms is unclear. Using whole-exome sequences of a large cohort of Ashkenazi Jewish centenarians to examine enrichment for rare coding variants, we found most longevity-associated rare coding variants converge upon conserved insulin/insulin-like growth factor 1 signaling and AMP-activating protein kinase signaling pathways. Centenarians have a number of pathogenic rare coding variants similar to control individuals, suggesting that rare variants detected in the conserved longevity pathways are protective against age-related pathology. Indeed, we detected a pro-longevity effect of rare coding variants in the Wnt signaling pathway on individuals harboring the known common risk allele APOE4. The genetic component of extreme human longevity constitutes, at least in part, rare coding variants in pathways that protect against aging, including those that control longevity in model organisms.

Indexed as

AgingLongevityAged, 80 and overAllelesCentenariansHumansSignal Transduction

Identifiers

PMID37117627
PMCPMC12434795
OpenAlexW3200400172

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.